IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,848,816 | +10.7% | 150,988 | +0.1% | 0.02% | +14.3% |
| Q2 2023 | $6,186,011 | +11.6% | 150,768 | -2.8% | 0.01% | +7.7% |
| Q1 2023 | $5,544,882 | -5.4% | 155,145 | 0.0% | 0.01% | -7.1% |
| Q4 2022 | $5,859,827 | -18.9% | 155,145 | -5.0% | 0.01% | -26.3% |
| Q3 2022 | $7,221,000 | +18.8% | 163,255 | -0.5% | 0.02% | +26.7% |
| Q2 2022 | $6,076,000 | -3.9% | 164,125 | -3.9% | 0.02% | +25.0% |
| Q1 2022 | $6,324,000 | +20.0% | 170,728 | -1.5% | 0.01% | +33.3% |
| Q4 2021 | $5,272,000 | -2.9% | 173,260 | +7.0% | 0.01% | -18.2% |
| Q3 2021 | $5,431,000 | -17.0% | 161,938 | -1.3% | 0.01% | -8.3% |
| Q2 2021 | $6,546,000 | -13.8% | 164,108 | -2.9% | 0.01% | -20.0% |
| Q1 2021 | $7,597,000 | -23.5% | 168,973 | -3.8% | 0.02% | -25.0% |
| Q4 2020 | $9,931,000 | +17.7% | 175,653 | -1.2% | 0.02% | +5.3% |
| Q3 2020 | $8,434,000 | -19.1% | 177,743 | +0.5% | 0.02% | -26.9% |
| Q2 2020 | $10,427,000 | +25.3% | 176,843 | +0.5% | 0.03% | +4.0% |
| Q1 2020 | $8,321,000 | -21.5% | 176,004 | +0.3% | 0.02% | -3.8% |
| Q4 2019 | $10,597,000 | -0.5% | 175,413 | -1.3% | 0.03% | -7.1% |
| Q3 2019 | $10,648,000 | -7.2% | 177,738 | -0.4% | 0.03% | -6.7% |
| Q2 2019 | $11,473,000 | -16.4% | 178,519 | +5.6% | 0.03% | -16.7% |
| Q1 2019 | $13,726,000 | +50.2% | 169,099 | +0.0% | 0.04% | +33.3% |
| Q4 2018 | $9,141,000 | +1.8% | 169,089 | -2.9% | 0.03% | +17.4% |
| Q3 2018 | $8,983,000 | +22.6% | 174,166 | -1.0% | 0.02% | +15.0% |
| Q2 2018 | $7,328,000 | -0.6% | 175,856 | +5.2% | 0.02% | 0.0% |
| Q1 2018 | $7,370,000 | -14.0% | 167,196 | -1.9% | 0.02% | -13.0% |
| Q4 2017 | $8,572,000 | -1.3% | 170,426 | -0.5% | 0.02% | -4.2% |
| Q3 2017 | $8,682,000 | -0.2% | 171,246 | +0.2% | 0.02% | -4.0% |
| Q2 2017 | $8,698,000 | +29.3% | 170,976 | +2.2% | 0.02% | +31.6% |
| Q1 2017 | $6,728,000 | -18.0% | 167,356 | -2.4% | 0.02% | -24.0% |
| Q4 2016 | $8,200,000 | +31.6% | 171,435 | +0.8% | 0.02% | +31.6% |
| Q3 2016 | $6,233,000 | +52.5% | 170,111 | -3.1% | 0.02% | +46.2% |
| Q2 2016 | $4,087,000 | -31.3% | 175,480 | +19.4% | 0.01% | -43.5% |
| Q1 2016 | $5,952,000 | -36.9% | 146,962 | -3.5% | 0.02% | -34.3% |
| Q4 2015 | $9,430,000 | – | 152,267 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |